Financhill
Sell
33

EYPT Quote, Financials, Valuation and Earnings

Last price:
$7.22
Seasonality move :
7.64%
Day range:
$6.90 - $7.42
52-week range:
$6.90 - $30.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.90x
P/B ratio:
2.22x
Volume:
4.2M
Avg. volume:
1M
1-year change:
-63.22%
Market cap:
$485.9M
Revenue:
$46M
EPS (TTM):
-$1.99

Earnings Data

Next earnings date for EYPT
Mar 07
2025
Most recent earnings per share
-$0.54
Missed by $0.00
(Nov 7/2024)
Consensus Estimate
-$0.54
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EYPT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/07/2025 Q4 $10.5M -- -- -$0.49 --
11/07/2024 Q3 $10.4M $10.5M -$0.54 -$0.54 -$0.00
08/07/2024 Q2 $10.6M $9.5M -$0.58 -$0.51 -$0.07
05/08/2024 Q1 $9.1M $11.7M -$0.55 -$0.42 -$0.13
03/07/2024 Q4 $8.7M $14M -$0.32 -$0.48 $0.16
11/01/2023 Q3 -- -- -$0.33 -$0.51 $0.18
08/02/2023 Q2 -- -- -$0.61 $0.37 -$0.98
05/03/2023 Q1 -- -- -$0.56 -$0.66 $0.10
03/02/2023 Q4 -- -- -$1.16 -$0.62 -$0.54
11/02/2022 Q3 -- -- -$0.49 -$0.69 $0.20
08/03/2022 Q2 -- -- -$0.52 -- --
05/04/2022 Q1 -- -- -$0.56 -- --
03/03/2022 Q4 -- -- -$0.59 -- --
11/03/2021 Q3 -- -- -$0.58 -- --
08/04/2021 Q2 -- -- -$0.35 -- --
05/05/2021 Q1 -- -- -$0.50 -- --
03/04/2021 Q4 -- -- -$1.07 -- --
11/05/2020 Q3 -- -- -$0.30 -- --
08/05/2020 Q2 -- -- -$1.04 -- --
05/06/2020 Q1 -- -- -$1.14 -- --
03/05/2020 Q4 -- -- -$1.00 -- --
11/07/2019 Q3 -- -- -$1.50 -- --
08/07/2019 Q2 -- -- -$1.10 -- --
05/08/2019 Q1 -- -- -$2.00 -- --
09/30/2018 Q3 -- -- -$4.40 -- --
06/30/2018 Q2 -- -- -$6.20 -- --
05/08/2018 Q1 -- -- -$1.50 -- --
02/07/2018 Q4 -- -- -$1.30 -- --
11/07/2017 Q3 -- -- -$1.50 -- --
09/11/2017 Q2 -- -- -$1.60 -- --
05/04/2017 Q1 -- -- -$1.50 -- --
02/07/2017 Q4 -- -- -$0.02 -- --
11/07/2016 Q3 -- -- -$2.10 -- --
09/12/2016 Q2 -- -- -$1.90 -- --
05/05/2016 Q1 -- -- -$1.50 -- --
02/08/2016 Q4 -- -- -$1.80 -- --
11/05/2015 Q3 -- -- -$1.70 -- --
09/09/2015 Q2 -- -- -$1.70 -- --
05/08/2015 Q1 -- -- -$1.70 -- --
02/05/2015 Q4 -- -- -$1.40 -- --

EyePoint Pharmaceuticals Earnings Questions

  • How Much did EyePoint Pharmaceuticals Generate in Revenue Last Quarter?

    EyePoint Pharmaceuticals reported $10.5M worth of top line sales in its most recent quarter.

  • Did EyePoint Pharmaceuticals Beat Earnings Last Quarter?

    EyePoint Pharmaceuticals announced earnings per share of -$0.54 which represents a miss of analyst forecast a -$0.54 per share.

  • Is EyePoint Pharmaceuticals Profitable?

    EyePoint Pharmaceuticals reported $9.8M that represents $0.18 per share over the last quarter.

  • What is the Analyst Consensus for EyePoint Pharmaceuticals EPS Next Year?

    EyePoint Pharmaceuticals's earnings are forecast to decrease from -$1.82 per share to -$1.92 per share next year representing a decrease of -22.15%.

  • When is EyePoint Pharmaceuticals's Earnings Date?

    EyePoint Pharmaceuticals's next earnings date is March 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 2.5% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 3% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock